Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Non-cash Items (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Non-cash Items for 16 consecutive years, with -$608029.0 as the latest value for Q1 2025.

  • On a quarterly basis, Non-cash Items fell 465.4% to -$608029.0 in Q1 2025 year-over-year; TTM through Mar 2025 was -$3.4 million, a 419.37% decrease, with the full-year FY2024 number at $58500.0, down 92.62% from a year prior.
  • Non-cash Items was -$608029.0 for Q1 2025 at GeoVax Labs, down from $509104.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $3.3 million in Q3 2023 to a low of -$3.5 million in Q3 2024.
  • A 5-year average of -$249086.2 and a median of $275044.0 in 2023 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: soared 586.37% in 2021, then plummeted 3171.69% in 2022.
  • GeoVax Labs' Non-cash Items stood at $499660.0 in 2021, then plummeted by 436.31% to -$1.7 million in 2022, then tumbled by 59.81% to -$2.7 million in 2023, then surged by 118.96% to $509104.0 in 2024, then tumbled by 219.43% to -$608029.0 in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Non-cash Items are -$608029.0 (Q1 2025), $509104.0 (Q4 2024), and -$3.5 million (Q3 2024).